Evidence map›Paper›PMID 26598701›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Altered Escherichia coli membrane protein assembly machinery allows proper membrane assembly of eukaryotic protein vitamin K epoxide reductase.

Feras Hatahet, Jessica L Blazyk, Eugenie Martineau, Eric Mandela, Yongxin Zhao, Robert E Campbell, Jonathan Beckwith, Dana Boyd

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Risk factors for quinolone-resistantAntimicrobial resistance and infection control · 2020
    Pooled it
  2. Giant viruses encode vitamin K-based redox modules for lipid modification.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Disulphide bond-forming enzymes in clostridial species.Microbiology (Reading, England) · 2025
    Article
  4. Article
  5. Review
  6. Distinct enzymatic strategies forCritical reviews in biochemistry and molecular biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Isolating Escherichia coli strains for recombinant protein production.Cellular and molecular life sciences : CMLS · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Feras HatahetDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Jessica L BlazykDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Eugenie MartineauDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Eric MandelaDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;
Yongxin ZhaoDepartment of Chemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Robert E CampbellDepartment of Chemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Jonathan BeckwithDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; jon_beckwith@hms.harvard.edu.
Dana BoydDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115;

Funding

Microbial Diversity in Mechanisms of Disulfide Bond Formation and ReductionR01GM041883 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BOYD, DANA · 1989 to 2014
$7.8M
Canadian Institutes of Health ResearchNIGMS NIH HHS R01 GM041883PHS HHS GMO41883
6 · The paper itself

Abstract

Functional overexpression of polytopic membrane proteins, particularly when in a foreign host, is often a challenging task. Factors that negatively affect such processes are poorly understood. Using the mammalian membrane protein vitamin K epoxide reductase (VKORc1) as a reporter, we describe a genetic selection approach allowing the isolation of Escherichia coli mutants capable of functionally expressing this blood-coagulation enzyme. The isolated mutants map to components of membrane protein assembly and quality control proteins YidC and HslV. We show that changes in the VKORc1 sequence and in the YidC hydrophilic groove along with the inactivation of HslV promote VKORc1 activity and dramatically increase its expression level. We hypothesize that such changes correct for mismatches in the membrane topogenic signals between E. coli and eukaryotic cells guiding proper membrane integration. Furthermore, the obtained mutants allow the study of VKORc1 reaction mechanisms, inhibition by warfarin, and the high-throughput screening for potential anticoagulants.

Indexed as

AnimalsChromosomes, BacterialEscherichia coliEscherichia coli ProteinsMembrane ProteinsMutationRatsVitamin K Epoxide ReductasesEscherichia coli ProteinsMembrane ProteinsVitamin K Epoxide Reductasesanticoagulantsmembrane protein assemblyVKORc1YidC

Identifiers

PMID26598701
PMCPMC4679017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.